IS8254A - örugg stökkbreytt veirubóluefni - Google Patents

örugg stökkbreytt veirubóluefni

Info

Publication number: IS8254A
Authority: IS; Iceland
Prior art keywords: viruses; vaccines; virus vaccine; mutant virus; mutations
Prior art date: 2003-07-29

Application number

IS8254A

Other languages

English (en)

Inventor

Wan Welch Saio-Kun

Gregory Calvert Jay

K. O'hara Michael

Cao Xuemei

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-29

Filing date

2006-01-23

Publication date

2006-01-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34272474&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8254(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-01-23 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2006-01-23 Publication of IS8254A publication Critical patent/IS8254A/is

Links

241000700605 Viruses Species 0.000 title abstract 6
229960005486 vaccine Drugs 0.000 title abstract 4
230000035772 mutation Effects 0.000 abstract 3
150000007523 nucleic acids Chemical class 0.000 abstract 2
102000039446 nucleic acids Human genes 0.000 abstract 2
108020004707 nucleic acids Proteins 0.000 abstract 2

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

IS8254A 2003-07-29 2006-01-23 örugg stökkbreytt veirubóluefni IS8254A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US49083403P	2003-07-29	2003-07-29
PCT/US2004/024011 WO2005021034A2 (en)	2003-07-29	2004-07-26	Safe mutant viral vaccines

Publications (1)

Publication Number	Publication Date
IS8254A true IS8254A (is)	2006-01-23

Family

ID=34272474

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8254A IS8254A (is)	2003-07-29	2006-01-23	örugg stökkbreytt veirubóluefni

Country Status (27)

Country	Link
US (2)	US7361357B2 (is)
EP (1)	EP1651263B9 (is)
JP (1)	JP4662931B2 (is)
KR (1)	KR100810820B1 (is)
CN (1)	CN1976717A (is)
AT (1)	ATE489107T1 (is)
AU (1)	AU2004268514B2 (is)
BR (1)	BRPI0413107A (is)
CA (1)	CA2533877C (is)
CY (1)	CY1110995T1 (is)
DE (1)	DE602004030253D1 (is)
DK (1)	DK1651263T3 (is)
EA (1)	EA009391B1 (is)
ES (1)	ES2355276T3 (is)
IL (1)	IL173338A0 (is)
IS (1)	IS8254A (is)
NO (1)	NO20060931L (is)
NZ (1)	NZ545612A (is)
PL (1)	PL1651263T3 (is)
PT (1)	PT1651263E (is)
RS (1)	RS51456B (is)
SI (1)	SI1651263T1 (is)
TN (1)	TNSN06031A1 (is)
TW (1)	TWI342783B (is)
UA (1)	UA85845C2 (is)
WO (1)	WO2005021034A2 (is)
ZA (1)	ZA200600585B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7179473B2 (en)	1998-06-05	2007-02-20	Boehringer Ingelheim Vetmedica Gmbh	Attenuated pestiviruses
US7135561B2 (en) *	2001-09-06	2006-11-14	Boehringer Ingelheim Vetmedica Gmbh	Infectious bovine viral diarrhea virus clone
US7361357B2 (en) *	2003-07-29	2008-04-22	Pfizer Inc.	Safe mutant viral vaccines
US7572455B2 (en) *	2004-05-19	2009-08-11	Boehringer Ingelheim Vetmedica Gmbh	Vaccine comprising an attenuated pestivirus
US8834891B2 (en) *	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
US20090068223A1 (en) *	2005-11-15	2009-03-12	Boehringer Ingelheim Vetmedica, Inc.	Combination vaccine comprising an attenuated bovine viral diarrhea virus
US7666585B2 (en) *	2007-06-15	2010-02-23	Protatek International, Inc.	Construction of chimera PRRSV, compositions and vaccine preparations
US8114852B2 (en) *	2008-01-15	2012-02-14	The United States Of America As Represented By The Secretary Of Agriculture	N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
UY31930A (es) *	2008-06-25	2010-01-29	Boheringer Ingelheim Pharma Kg	Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
WO2010064164A1 (en) *	2008-12-03	2010-06-10	Pfizer Inc.	Bovine viral diarrhea virus with a modified erns protein
US8846054B2 (en) *	2009-01-09	2014-09-30	Boehringer Ingelheim Vetmedica, Inc.	Method of treating pregnant cows and/or heifers
WO2012092053A1 (en) *	2010-12-27	2012-07-05	Eli Lilly And Company	Bovine viral diarrhea virus type 1b vaccine compositions and methods
RU2457859C1 (ru) *	2011-01-12	2012-08-10	Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ")	Вакцина против вирусной диареи крупного рогатого скота
CN105985413A (zh) *	2015-02-28	2016-10-05	中国科学院上海巴斯德研究所	新的甲型流感病毒哺乳动物细胞适应株及其制备和应用
KR102580161B1 (ko)	2017-08-02	2023-09-20	순천향대학교 산학협력단	백신의 중추신경계 안전성 검사를 위한 양성대조군의 제조방법 및 이를 이용한 검사 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
US6001613A (en) *	1996-05-24	1999-12-14	Board Of Regents Of University Of Nebraska	Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
ES2232934T3 (es)	1997-02-14	2005-06-01	MERCK & CO., INC.	Formulaciones de vacunas a base de polinucleotidos.
RS20050177A (sr)	2002-08-26	2007-06-04	Pfizer Products Inc.,	Vakcina za infekcije respiratornog i reproduktivnog sistema kod stoke
US7563449B2 (en) *	2003-04-21	2009-07-21	Pfizer Inc,	Methods for reducing cattle reproductive diseases
US7361357B2 (en)	2003-07-29	2008-04-22	Pfizer Inc.	Safe mutant viral vaccines

2004
- 2004-07-16 US US10/893,712 patent/US7361357B2/en not_active Expired - Fee Related
- 2004-07-26 AU AU2004268514A patent/AU2004268514B2/en not_active Ceased
- 2004-07-26 UA UAA200600830A patent/UA85845C2/uk unknown
- 2004-07-26 CA CA2533877A patent/CA2533877C/en not_active Expired - Fee Related
- 2004-07-26 KR KR1020067002112A patent/KR100810820B1/ko not_active Expired - Fee Related
- 2004-07-26 CN CNA2004800283626A patent/CN1976717A/zh active Pending
- 2004-07-26 EP EP04801973A patent/EP1651263B9/en not_active Revoked
- 2004-07-26 NZ NZ545612A patent/NZ545612A/en unknown
- 2004-07-26 DE DE602004030253T patent/DE602004030253D1/de not_active Expired - Lifetime
- 2004-07-26 PT PT04801973T patent/PT1651263E/pt unknown
- 2004-07-26 SI SI200431575T patent/SI1651263T1/sl unknown
- 2004-07-26 RS YUP-2006/0045A patent/RS51456B/sr unknown
- 2004-07-26 PL PL04801973T patent/PL1651263T3/pl unknown
- 2004-07-26 JP JP2006521967A patent/JP4662931B2/ja not_active Expired - Fee Related
- 2004-07-26 DK DK04801973.1T patent/DK1651263T3/da active
- 2004-07-26 ES ES04801973T patent/ES2355276T3/es not_active Expired - Lifetime
- 2004-07-26 WO PCT/US2004/024011 patent/WO2005021034A2/en not_active Ceased
- 2004-07-26 BR BRPI0413107-0A patent/BRPI0413107A/pt not_active Application Discontinuation
- 2004-07-26 AT AT04801973T patent/ATE489107T1/de active
- 2004-07-26 EA EA200600121A patent/EA009391B1/ru not_active IP Right Cessation
- 2004-07-28 TW TW093122607A patent/TWI342783B/zh not_active IP Right Cessation
2006
- 2006-01-20 ZA ZA200600585A patent/ZA200600585B/en unknown
- 2006-01-23 IS IS8254A patent/IS8254A/is unknown
- 2006-01-24 IL IL173338A patent/IL173338A0/en unknown
- 2006-01-27 TN TNP2006000031A patent/TNSN06031A1/fr unknown
- 2006-02-27 NO NO20060931A patent/NO20060931L/no not_active Application Discontinuation
2008
- 2008-04-04 US US12/098,015 patent/US7754222B2/en not_active Expired - Lifetime
2010
- 2010-12-16 CY CY20101101159T patent/CY1110995T1/el unknown

Also Published As

Publication number	Publication date
EP1651263B9 (en)	2011-02-16
ZA200600585B (en)	2007-03-28
JP2007500702A (ja)	2007-01-18
EA200600121A1 (ru)	2006-10-27
EP1651263A2 (en)	2006-05-03
CN1976717A (zh)	2007-06-06
DE602004030253D1 (de)	2011-01-05
TW200514568A (en)	2005-05-01
RS20060045A (sr)	2008-06-05
ES2355276T3 (es)	2011-03-24
EP1651263B1 (en)	2010-11-24
PL1651263T3 (pl)	2011-04-29
BRPI0413107A (pt)	2006-10-03
US7361357B2 (en)	2008-04-22
ES2355276T9 (es)	2011-03-25
WO2005021034A3 (en)	2005-12-29
CA2533877C (en)	2011-09-06
US20050053621A1 (en)	2005-03-10
TNSN06031A1 (fr)	2007-10-03
KR20060092198A (ko)	2006-08-22
EA009391B1 (ru)	2007-12-28
US20080286302A1 (en)	2008-11-20
CY1110995T1 (el)	2015-06-11
RS51456B (sr)	2011-04-30
US7754222B2 (en)	2010-07-13
JP4662931B2 (ja)	2011-03-30
AU2004268514A1 (en)	2005-03-10
DK1651263T3 (da)	2011-01-31
UA85845C2 (uk)	2009-03-10
WO2005021034A2 (en)	2005-03-10
KR100810820B1 (ko)	2008-03-06
NO20060931L (no)	2006-04-27
TWI342783B (en)	2011-06-01
NZ545612A (en)	2009-11-27
AU2004268514B2 (en)	2010-01-21
SI1651263T1 (sl)	2011-02-28
ATE489107T1 (de)	2010-12-15
CA2533877A1 (en)	2005-03-10
IL173338A0 (en)	2006-06-11
PT1651263E (pt)	2011-01-25

Publication	Publication Date	Title
CY1110995T1 (el)	2015-06-11	Ασφαλη μεταλλακτικα ιικα εμβολια
Heaton et al.	2013	Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins
SI1554301T1 (sl)	2011-01-31	VAKCINA ZA DENGO, KI VSEBUJE SKUPNO DELECIJO 30 NUKLEOTIDOV V 3ĹľUTR TIPOV 1 IN 2 DENGE
FI3581650T3 (fi)	2023-03-23	IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi
DK1030690T3 (da)	2002-10-21	Rekombinante vacciner, der omfatter immunogene svækkede bakterier med RpoS positiv fænotype
Kerr et al.	2013	Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread
NZ597601A (en)	2013-04-26	Treatment and prevention of influenza
WO2003023040A3 (en)	2003-11-27	Vaccinia virus mva-e3l-knockout-mutants and use thereof
ATE413888T1 (de)	2008-11-15	Salmonella vakzine
WO2011119716A3 (en)	2012-03-15	Flavivirus host range mutations and uses thereof
DK1425038T3 (da)	2006-03-27	Svækkede bakterier, der er anvendelige i vacciner
NO20004781D0 (no)	2000-09-25	Svekkede bakterier anvendelige i vaksiner
WO2006136448A3 (en)	2007-07-19	Attenuated sars and use as a vaccine
D’Andrea et al.	2011	A detailed comparative analysis on the overall codon usage patterns in hepatitis A virus
WO2012003320A3 (en)	2012-05-18	Flavivirus host-range mutations and uses thereof
EA200701695A1 (ru)	2008-02-28	Рнк вирусы с ослабленной способностью к репликации в качестве вакцин
EA200301151A1 (ru)	2004-10-28	Вакцина против натуральной оспы
Akaishi	2022	Comparison of insertion, deletion, and point mutations in the genomes of human adenovirus HAdvC-2 and SARS-CoV-2
ATE427119T1 (de)	2009-04-15	Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
WO2003080112A3 (en)	2003-11-06	Imidazoquinolineamines as adjuvants in hiv dna vaccination
ATE408013T1 (de)	2008-09-15	Infektiöses cdna klon des gb-virus b und dessen verwendungen
DE50312368D1 (de)	2010-03-11	Rekombinante mva-stamme als potentielle impfstoffe gegen p. falciparum -malaria
DK1074266T3 (da)	2007-04-10	Levende svækkede bakterier til anvendelse i vaccine
Bosch et al.	2010	Coding biases and viral fitness
WO2001087939A3 (en)	2002-03-28	Genes required for natural competence, proteins, and their use